Achillion Names Dr. Joel Barrish as Chief Scientific Officer
January 04, 2016 at 06:21 AM EST
Achillion Pharmaceuticals, Inc. (Nasdaq: ACHN) today announced that Joel Barrish, Ph.D., has been named the Company's Chief Scientific ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.